BiotechTube
Home/CicloMed/Tammy Ham
TH

Tammy Ham

Chief Executive Officer

CicloMed

Therapeutic Areas

Oncology

CicloMed Pipeline

DrugIndicationPhase
Fosciclopirox (Ciclopirox Prodrug)Cisplatin-ineligible Muscle-Invasive Bladder Cancer (MIBC)Phase 1

Leadership Team at CicloMed

WM
William McCulloch, M.B., Ch.B., F.R.C.P., F.F.P.M.
Acting Chief Medical Officer and Chair of the Clinical Advisory Board
SJ
Scott J. Weir, Pharm.D., Ph.D.
Acting Chief Scientific Officer
View full CicloMed profile